Advertisement

Topics

Latest "Longlife Holding 4355 Financial Strategic SWOT Analysis Review" News Stories

10:11 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Longlife Holding 4355 Financial Strategic SWOT Analysis Review" found in our extensive news archives from over 250 global news sources.

More Information about Longlife Holding 4355 Financial Strategic SWOT Analysis Review on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Longlife Holding 4355 Financial Strategic SWOT Analysis Review for you to read. Along with our medical data and news we also list Longlife Holding 4355 Financial Strategic SWOT Analysis Review Clinical Trials, which are updated daily. BioPortfolio also has a large database of Longlife Holding 4355 Financial Strategic SWOT Analysis Review Companies for you to search.

Showing "Longlife Holding 4355 Financial Strategic SWOT Analysis Review" News Articles 1–25 of 26,000+

Monday 25th March 2019

CIRCULOGENE’s Precision Genomic Profiling Technology Featured in Three AACR 2019 Abstracts

Posters present data on utility of cfDNA for patient mutation load in NSCLC; cfRNA PD-L1 + MSI single-blood-tube testing; and innovative salvage of buccal NGS testing CIRCULOGENE, advancing precision medicine through personalized molecular genetics testing, will be presenting three abstracts at the 2019


Monarch Medical Technologies Appoints Bruce Lisanti as New President and Chief Executive Officer

Monarch Medical Technologies, the leader in precision insulin dosing technology for optimized glycemic management, today announced that Bruce Lisanti has been named president and chief executive officer, effective immediately. Lisanti succeeds Linda Beneze who retired from her role as Monarch CEO. “On behalf of the board, we first would l...

Seodong Medical launches new device for treating dry eye syndrome

Seodong Medical’s NURIEYE-5800, a medical vibrator, is an innovative device that treats dry eye syndrome known as a core factor of hampering health of eyeballs. NURIEYE-5800 was approved The post Seodong Medical launches new device for treating dry eye syndrome appeared first on Compelo Medical Devices - Latest industry news and analysis.


Varex agrees to acquire Direct Conversion for $75m

Varex said that for 100% of the common stock on Direct Conversion, it will pay $75m, out of which $10m will be paid either in Varex stock or The post Varex agrees to acquire Direct Conversion for $75m appeared first on Compelo Medical Devices - Latest industry news and analysis.

Researchers use radiomics to predict which lung cancer patients will respond to chemotherapy

According to RSNA, researchers stated that radiomic feature maps show the differences between the lesions in responders and non-responders in the pretreatment CT scans. They found that radiomic The post Researchers use radiomics to predict which lung cancer patients will respond to chemotherapy appeared first on Compelo Medical Devices - Latest industry news and analysis.

Genetesis secures FDA 510(k) clearance for cardiac imaging platform

Genetesis said that its cardiac imaging platform works by pairing the CardioFlux Magnetocardiograph with the integrated Faraday Analytical Cloud (FAC). CardioFlux technology allows simple, rapid, non-invasive cardiac imaging. The post Genetesis secures FDA 510(k) clearance for cardiac imaging platform appeared first on Compelo Medical Devices - Latest industry news and analysis.

Philips, Delta Dental of California partner to advance oral health and improve healthcare outcomes

The companies plan to lend their respective expertise and conduct research in a joint effort to build integrated insurance and oral hygiene and wellness solutions within an evolving The post Philips, Delta Dental of California partner to advance oral health and improve healthcare outcomes appeared first on Compelo Medical Devices - Latest industry news and analysis.

Lantheus Announces Upcoming Retirement of Chief Medical Officer in September 2019 and Promotion of Senior Vice President, Technical Operations to Chief Operations Officer

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced that Cesare Orlandi, M.D., Chief Medical Officer, will retire from the Company on September 2, 2...

AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights

Entered into a merger agreement with C3J Therapeutics that is expected to result in an NYSE American-listed company focused on development of precisely-targeted bacteriophage therapeutics $10.0 million of new capital will be invested in combined company to be re-named Armata Pharmaceuticals Preliminary Merger pr...

3 Health System Leaders to Deliver Keynote Presentations at the Becker's Health It + Clinical Leadership + Pharmacy Conference

Becker's Hospital Review welcomes 170-plus talented medical professionals as speakers for its Health IT + Clinical Leadership + Pharmacy Conference, held May 2-4 at the Swissotel in Chicago. CHICAGO (PRWEB) March 25, 2019 Becker's Hospital Review welcomes 170-plus talented medical professionals as speakers for its Health IT + Clinical Leadership + Pharmacy Conference, held May 2-4 at the ...

Compulink Showcases SMART Audiology-Specific EHR at AAA 2019

Compulink Healthcare Solutions, the creator of Advantage SMART Practice®, an all-in-one EHR and practice management solution powered by artificial intelligence (AI), will demonstrate the latest enhancements to

Charles G. Berg Joins Turn-Key Health Board of Directors: Executive Leader at DaVita Medical Group, WellCare, UnitedHealth and Oxford

Turn-Key Health (Turn-Key), an Enclara Healthcare company, serving health plans, provider organizations and their members who experience a serious or advanced illness, welcomes Charles “Chuck” Berg, a veteran healthcare executive who has served in various leadership roles throughout the industry, to its board of directors. Currently, he is on the ...

Netsmart Delivers More for Whole-Person Care at NatCon19

Netsmart will showcase how organizations are leading the journey to make whole-person care a reality at the nation’s largest behavioral health conference, National Council for Behavioral Health’s

Xeris Pharmaceuticals Presents New Clinical and Economic Impact Data on Its Developmental Ready-to-Use Glucagon

Data from a Phase 2 study in congenital hyperinsulinism (CHI) shared at ENDO 2019 and a budget impact model presented at AMCP reinforce the utility of Xeris’ ready-to-use, liquid-stable glucagon Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-t...

Turning Point Therapeutics Appoints Jim Mazzola to Lead Corporate Communication and Investor Relations

Turning Point Therapeutics, Inc., a clinical-stage precision oncology company designing and developing novel drugs to address treatment resistance, announced today the appointment of Jim Mazzola to lead corporate communication and investor relations, reporting to Chief Executive Officer Athena Countouriotis, M.D. "Jim joins at a pivotal ...

21st Century HPLC Management in Your Laboratory

Today’s High Tech laboratory environment demands the best results, achieved using the latest safety and production solutions. Combined with the best consumables and equipment HPLC is a powerful tool in analysis, a must for today’s results driven, cost conscious laboratory. Whatever HPLC/UHPLC method is used in the lab, choosing the right solvents and safety handling equipment is a very...

Flare Capital Partners Appoints Parth Desai as Senior Associate

Expands Investment Team to Reinvent the Business of Healthcare Flare Capital Partners, a leading healthcare technology venture capital firm, today announced the addition of healthcare technology investor and experienced policy professional Parth Desai as a Senior Associate. “Parth has dedicated his

Saama Closes $40 Million Financing with Perceptive Advisors to Drive Disruption in Clinical Analytics and Drug Development

Saama Technologies, Inc. (“Saama”), a leading clinical data analytics platform firm, announced that it has closed a $40 million financing with Perceptive Advisors. The new funding will be used to support the expansion of Saama’s Life Science Analytics Cloud (LSAC), an AI-powered platform disrupting the planning, designing and conduct of clinical tria...

NantKwest Chairman & CEO Dr. Patrick Soon-Shiong Exercises $39 Million in Warrants and Options in Support of NK’s Natural Killer Cell Strategic Vision Beyond Check Point Immunotherapy

Completion of Phase 1 First-in-Human Trials of Cryopreserved, Off-The-Shelf haNK Cells Leads the Way to Pivotal Phase 2 Trials in Relapsed Merkel Cell Carcinoma Funding to Support INDs for First-in-Human Targeted Off-The-Shelf NK Cells (t-haNKs) with PD-L1 and CD-19 as Tumor Targets

Donor Features, Procedures and Outcomes in Fecal Transplant

This comprehensive review examined donor characteristics and screening protocols for fecal microbiota transplantation, as well as FMT procedures and outcomes. Alimentary Pharmacology & Therapeutics

Nexstim Plc: Resolutions of the annual general meeting of shareholders, 25 March 2019

Company announcement, Helsinki, 25 March 2019, at 12 PM Nexstim Plc: Resolutions of the annual general meeting of shareholders, 25 March 2019Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major D...

Bristol-Myers Squibb Board of Directors Sends Letter to Shareholders Highlighting the Compelling Strategic and Financial Rationale of the Celgene Transaction; Company Provides Additional Investor Materials

Urges Shareholders to Vote “FOR” the Proposed Transaction on the WHITE Proxy Card Bristol-Myers Squibb Company’s (NYSE:BMY) Board of Directors today sent an open letter to the Company’s shareholders regarding the previously announced definitive merger agreement with Celgene Corporation (NASDAQ:CELG). In addition to its March 19 investor present...

Aerie Pharmaceuticals Announces Four Appointments

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye today announced the appointment of David Ellis, Ph.D., as Director, Chemistry, reporting ...

Novartis meets key conditions for spin-off of Alcon eye care division

On February 2018, the planned 100% spin-off of Alcon eye care business has been approved at the Annual General Meeting of shareholders of Novartis. In June 2018, Novartis The post Novartis meets key conditions for spin-off of Alcon eye care division appeared first on Compelo Medical Devices - Latest industry news and analysis.

Fuse Medical Reports Full Year 2018 Financial Results with Record Earnings

Fuse Medical, Inc., (OTCPINK: FZMD), an emerging manufacturer and distributor of medical devices for the orthopedic and spine marketplace, announced record earnings for the fiscal year ended December 31, 2018. Fuse filed its annual report on Form 10-K with the Securities and Exchange Commission on Thursday, March 21, 2019. 2018 Financial Highlight...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks